The preprint abstract reports computational generation of 500,000 candidate transcriptional activation domains and selection of 18,750 high-scoring sequences for yeast experiments using sequence-to-function models including three neural networks. More than 90% of 16,770 well-measured sequences functioned as activation domains. Some designed sequences retained activity in fungi, plants and human cells. Model agreement motivated the MADRIGAL consensus predictor. Review is limited to the abstract and original-server metadata.
Technology: Neural-network sequence-to-function models (three networks); consensus predictor MADRIGAL
Publication: Preprint · Test context: direct test. Catalog categories, not an evidence grade.
Result, AI contribution and limits
Evidence context (descriptions follow the cited sources; test type is a catalog classification):
- Publication status: Preprint
- Test type: direct test
- Tested: 18,750 selected sequences were tested experimentally in yeast; over 90% of 16,770 well-measured sequences functioned as activation domains, and some retained function in fungi, plants and human cells.
- Still unknown: Review limited to the indexed abstract and publication metadata; full-paper methods and additional limitations were not assessed.
- AI role: Neural networks scored sequences generated from known activation-domain-like sequences; high-scoring sequences were selected for experimental validation and the consensus model MADRIGAL was developed.
Evidence sources: https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=DOI%3A%2210.64898%2F2026.10.30.763198%22&resultType=core&format=json · https://api.biorxiv.org/details/biorxiv/10.64898/2026.10.30.763198
Source checked · editorial details
The source page was checked against this entry. Independent confirmation is not assessed by this label.
Source type: paper. Paper: linked separately.
Review scope and date are not recorded; source checked does not establish full-text review.
Editorial assessment: Impact 3/5 · Validation 3/5 · Novelty 3/5. Impact and novelty are editorial judgments; validation follows the annotated test type where one exists. Not an evidence grade. Scoring criteria.
Follow-up and relationships
No follow-up recorded; this is not a claim that no follow-up exists.
Follow-up review scope and date are not recorded.
No source-supported relationships recorded.
The Nature paper, published online on 2026-06-24, reports a deep-learning ECG biomarker evaluated retrospectively in Swedish data and external US and Taiwanese datasets. Its high-risk group comprised 2.2% of the sample and had a 7.0% annual sudden-cardiac-death rate, versus 4.6% for reduced LVEF; 86.1% were not flagged by LVEF. Among high-risk patients with defibrillators, sudden cardiac death was 54.4% lower than model-expected, an observational association subject to confounding and not proof of benefit.
Technology: Deep learning ECG model with a generative ECG waveform model for visualization
Publication: Peer-reviewed paper · Test context: retrospective or benchmark. Catalog categories, not an evidence grade.
Result, AI contribution and limits
Evidence context (descriptions follow the cited sources; test type is a catalog classification):
- Publication status: Peer-reviewed paper
- Test type: retrospective or benchmark
- Tested: Existing Swedish ECG/death-certificate data, a held-out lockbox created before analysis, external US ventricular-arrhythmia and Taiwanese arrhythmic-arrest evaluations; observational defibrillator associations.
- Still unknown: Main paper reviewed; supplementary attachments not read. The authors explicitly identify residual confounding and the need for randomized testing of defibrillator benefit in model-high-risk patients.
- AI role: Deep learning model discovered the predictive ECG waveform pattern; generative model used to visualize it.
Evidence sources: https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=DOI%3A%2210.1038%2Fs41586-026-10674-6%22&resultType=core&format=json · https://www.ebi.ac.uk/europepmc/webservices/rest/PMC13323061/fullTextXML
Source checked · editorial details
The source page was checked against this entry. Independent confirmation is not assessed by this label.
Source type: paper. Paper: not linked in this catalog; this does not mean no paper exists.
Review scope and date are not recorded; source checked does not establish full-text review.
Editorial assessment: Impact 4/5 · Validation 2/5 · Novelty 4/5. Impact and novelty are editorial judgments; validation follows the annotated test type where one exists. Not an evidence grade. Scoring criteria.
Follow-up and relationships
No follow-up recorded; this is not a claim that no follow-up exists.
Follow-up review scope and date are not recorded.
No source-supported relationships recorded.
AIRES combined probabilistic machine-learning predictions with robotic synthesis, optical crystal screening and single-crystal X-ray diffraction to explore zinc zeolitic imidazolate frameworks. The campaign crystallized new structures using 10 of 48 previously untested linkers, doubling the discovery rate of random exploration (700 versus 1,400 experiments) and increasing the single-linker Zn-ZIF library by about one-third. The paper reports structure-resolved products, including eleven previously unreported crystals across its discovery campaign.
Technology: Algorithmic Iterative Reticular Synthesis (AIRES)
Publication: Peer-reviewed paper · Test context: direct test. Catalog categories, not an evidence grade.
Result, AI contribution and limits
Evidence context (descriptions follow the cited sources; test type is a catalog classification):
- Publication status: Peer-reviewed paper
- Test type: direct test
- Tested: AIRES combined probabilistic machine-learning predictions with robotic synthesis, optical crystal screening and single-crystal X-ray diffraction to explore zinc zeolitic imidazolate frameworks.
- Still unknown: This is one paper-level experimental discovery campaign. The reported efficiency comparison is against a random-exploration baseline within the study, not an independent replication. Structures were identified by single-crystal X-ray diffraction; the paper describes discovery of ZIF crystals but does not establish application performance. The campaign covered a defined single-linker Zn-ZIF chemical and reaction space, not all reticular materials.
- AI role: AIRES used probabilistic random-forest and Gaussian-process crystallization models to guide experiment selection across linker chemistries and reaction conditions. Its greedy and batch decision rules prioritized experiments predicted to yield distinct new crystals; automated synthesis, computer-vision crystal screening and subsequent single-crystal X-ray diffraction supplied experimental outcomes for model updates and structure determination. The AI-guided campaign found structures for 10 of 48 new linkers, with twice the distinct-crystal discovery rate of random exploration.
Evidence sources: https://www.nature.com/articles/s44160-025-00939-9
Source checked · editorial details
The source page was checked against this entry. Independent confirmation is not assessed by this label.
Source type: paper. Paper: linked separately.
Review scope and date are not recorded; source checked does not establish full-text review.
Editorial assessment: Impact 3/5 · Validation 3/5 · Novelty 3/5. Impact and novelty are editorial judgments; validation follows the annotated test type where one exists. Not an evidence grade. Scoring criteria.
Follow-up and relationships
No follow-up recorded; this is not a claim that no follow-up exists.
Follow-up review scope and date are not recorded.
No source-supported relationships recorded.
AcRanker, an XGBoost ranking model using amino-acid sequence features, ranked proteins from prophage regions in self-targeting Streptococcus genomes. Experimental testing identified two previously unknown type II-A anti-CRISPRs: AcrIIA20 (ML1), which strongly inhibited Streptococcus iniae Cas9 and weakly inhibited S. pyogenes Cas9, and AcrIIA21 (ML8), which inhibited S. pyogenes, S. aureus and S. iniae Cas9 with lower potency.
Technology: AcRanker, an XGBoost pairwise ranking model trained on amino-acid composition and grouped di- and tri-mer features
Publication: Peer-reviewed paper · Test context: direct test. Catalog categories, not an evidence grade.
Result, AI contribution and limits
Evidence context (descriptions follow the cited sources; test type is a catalog classification):
- Publication status: Peer-reviewed paper
- Test type: direct test
- Tested: Experimental testing identified two previously unknown type II-A anti-CRISPRs: AcrIIA20 (ML1), which strongly inhibited Streptococcus iniae Cas9 and weakly inhibited S. pyogenes Cas9, and AcrIIA21 (ML8), which inhibited S. pyogenes, S. aureus and S. iniae Cas9 with lower potency.
- Still unknown: The authors selected 10 candidates for follow-up, successfully purified nine and reported three validated candidates across their experiments, including ML3/AcrIIA12, which had also been identified separately as an LmoCas9 inhibitor during the study. AcrIIA20 and AcrIIA21 were roughly tenfold less potent against SpyCas9 than the established AcrIIA4 control; tested potency and host range are assay-specific. The 2025 Evo paper reports distinct generated proteins EvoAcr1–5 and separate assays; shared anti-CRISPR function does not make these identical discoveries.
- AI role: The model ranked candidate proteins from predicted prophage regions for anti-CRISPR likelihood; the researchers selected candidates from those rankings and biochemically tested them. It directly prioritized the proteins later named AcrIIA20 and AcrIIA21, whose Cas9 inhibition was measured in vitro.
Evidence sources: https://academic.oup.com/nar/article/48/9/4698/5819938
Source checked · editorial details
The source page was checked against this entry. Independent confirmation is not assessed by this label.
Source type: paper. Paper: linked separately.
Review scope and date are not recorded; source checked does not establish full-text review.
Citations: in the top 10% of works of the same type, year and subfield (OpenAlex work metrics, 125 citations; as of 15 Nov 2026). Attention, not a measure of correctness; not part of the score.
Editorial assessment: Impact 3/5 · Validation 3/5 · Novelty 3/5. Impact and novelty are editorial judgments; validation follows the annotated test type where one exists. Not an evidence grade. Scoring criteria.
Follow-up and relationships
No follow-up recorded; this is not a claim that no follow-up exists.
Follow-up review scope and date are not recorded.
No source-supported relationships recorded.